7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one
C22H22FN5O — CID 156888890
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one
7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one (PubChem CID 156888890) has the molecular formula C22H22FN5O and a molecular weight of 391.45 g/mol. Its IUPAC name is 7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one.
Molecular Properties
| Compound Name | 7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one |
|---|---|
| PubChem CID | 156888890 |
| Molecular Formula | C22H22FN5O |
| Molecular Weight | 391.45 g/mol |
| Exact Mass | 391.18 |
| IUPAC Name | 7-(8-fluoro-2-methylimidazo[1,2-a]pyridin-6-yl)-3-[(2R,4R)-2-methylpiperidin-4-yl]quinazolin-4-one |
| SMILES | Cc1cn2cc(-c3ccc4c(=O)n([C@@H]5CCN[C@H](C)C5)cnc4c3)cc(F)c2n1 |
| InChI | InChI=1S/C22H22FN5O/c1-13-7-17(5-6-24-13)28-12-25-20-9-15(3-4-18(20)22(28)29)16-8-19(23)21-26-14(2)10-27(21)11-16/h3-4,8-13,17,24H,5-7H2,1-2H3/t13-,17-/m1/s1 |
| InChIKey | KCYMJCJJIVJOAF-CXAGYDPISA-N |
| XLogP | 3.47 |
| TPSA | 64.22 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 391.45 |
| LogP ≤ 5 | 3.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156888890 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.